CoChat

Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians

Gartlehner, Gerald, Gaynes, Bradley N., Amick, Halle R., Asher, Gary N., Morgan, Laura C., Coker-Schwimmer, Emmanuel, Forneris, Catherine, Boland, Erin, Lux, Linda J., Gaylord, Susan, Bann, Carla, Pierl, Christiane Barbara, Lohr, Kathleen N. · 2016 · Annals of Internal Medicine
Cited by 132

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Primary care patients and clinicians may prefer options other than second-generation antidepressants for the treatment of major depressive disorder (MDD). The comparative benefits and harms of antidepressants and alternative treatments are unclear. PURPOSE: To compare the benefits and harms of second-generation antidepressants and psychological, complementary and alternative medicine (CAM), and exercise treatments as first- and second-step interventions for adults with acute MDD. DATA SOURCES: English-, German-, and Italian-language studies from multiple electronic databases (January 1990 to September 2015); trial registries and gray-literature databases were used to identify unpublished research. STUDY SELECTION: Two investigators independently selected comparative randomized trials of at least 6 weeks' duration on health outcomes of adult outpatients; nonrandomized studies were eligible for harms. DATA EXTRACTION: Reviewers abstracted data on study design, participants, interventions, and outcomes; rated the risk of bias; and graded the strength of evidence. A senior reviewer confirmed data and ratings. DATA SYNTHESIS: 45 trials met inclusion criteria. On the basis of moderate-strength evidence, cognitive behavioral therapy (CBT) and antidepressants led to similar response rates (relative risk [RR], 0.90 [95% CI, 0.76 to 1.07]) and remission rates (RR, 0.98 [CI, 0.73 to 1.32]). In trials, antidepressants had higher risks for adverse events than most other treatment options; no information from nonrandomized studies was available. The evidence was too limited to make firm conclusions about differences in the benefits and harms of antidepressants compared with other treatment options as first-step therapies for acute MDD. For second-step therapies, different switching and augmentation strategies provided similar symptom relief. LIMITATION: High dropout rates, dosing inequalities, small sample sizes, and poor assessment of adverse events limit confidence in the evidence. CONCLUSION: Given their similar efficacy, CBT and antidepressants are both viable choices for initial treatment of MDD. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/m15-1813

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 51

  1. Rimer J, 2012, Cochrane Database Syst Rev, 7, CD004366
  2. Maratos AS, 2008, Cochrane Database Syst Rev, CD004517
  3. Jorm AF, 2008, Cochrane Database Syst Rev, CD007142
  4. Smith CA, 2010, Cochrane Database Syst Rev, CD004046
  5. Cooney GM, 2013, Cochrane Database Syst Rev, 9, CD004366
  6. De Berardis D, 2015, CNS Neurol Disord Drug Targets
  7. 10.1136/bmj.d5928 · DOI · Paper page
  8. 10.1016/S0149-2918(00)89010-4 · DOI · Paper page
  9. 10.1097/01.jcp.0000178416.60426.29 · DOI · Paper page
  10. 10.1017/S0033291710000553 · DOI · Paper page
  11. 10.1017/S1461145709000224 · DOI · Paper page
  12. 10.1080/00048670701827275 · DOI · Paper page
  13. 10.4088/JCP.13m08591 · DOI · Paper page
  14. 10.1590/S1516-44462006000100007 · DOI · Paper page
  15. 10.1176/ps.2009.60.3.337 · DOI · Paper page
  16. Shamsaei F, 2008, Hong Kong Journal of Psychiatry, 18, 76
  17. 10.1016/j.jad.2006.07.012 · DOI
  18. 10.1089/acm.2011.0637 · DOI · Paper page
  19. 10.1001/jama.290.1.57 · DOI · Paper page
  20. 10.1016/j.jad.2013.08.036 · DOI
  21. 10.1136/bmj.320.7226.26 · DOI · Paper page
  22. 10.1159/000151388 · DOI · Paper page
  23. 10.1192/bjp.bp.112.122663 · DOI · Paper page
  24. 10.1002/jclp.20487 · DOI · Paper page
  25. 10.1016/j.jad.2007.10.015 · DOI
  26. 10.1159/000104705 · DOI · Paper page
  27. 10.1002/jclp.20550 · DOI · Paper page
  28. 10.1002/da.20758 · DOI · Paper page
  29. 10.1002/da.20585 · DOI
  30. 10.4103/1673-5374.125353 · DOI
  31. Huang Y, 2005, International Journal of Clinical Acupuncture, 14, 7
  32. 10.1016/j.jpsychires.2013.02.004 · DOI
  33. 10.1089/acm.2008.0607 · DOI · Paper page
  34. 10.1007/BF02850017 · DOI
  35. 10.1007/s00406-004-0532-z · DOI
  36. 10.1001/jama.287.14.1807 · DOI · Paper page
  37. 10.1055/s-2005-837807 · DOI · Paper page
  38. 10.1055/s-2006-931544 · DOI · Paper page
  39. Harrer G, 1999, Arzneimittelforschung, 49, 289
  40. 10.1159/000115779 · DOI
  41. 10.1097/00004850-200015020-00001 · DOI · Paper page
  42. 10.1136/bmj.38356.655266.82 · DOI · Paper page
  43. van Gurp G, 2002, Can Fam Physician, 48, 905
  44. 10.1136/bmj.h4320 · DOI · Paper page
  45. 10.1249/MSS.0b013e31816b877c · DOI · Paper page
  46. 10.1192/bjp.bp.114.150516 · DOI · Paper page
  47. 10.1097/YIC.0b013e3282f424c2 · DOI · Paper page
  48. 10.1016/j.jad.2009.07.005 · DOI · Paper page
  49. 10.1097/NMD.0b013e31820caefb · DOI · Paper page
  50. Linde K, 2008, Cochrane Database Syst Rev, CD000448
  51. 10.1016/j.euroneuro.2008.08.009 · DOI · Paper page

Cited by

See all 132

Metadata

Authors
Gartlehner, G., Gaynes, B. N., Amick, H. R., Asher, G. N., Morgan, L. C., Coker-Schwimmer, E., Forneris, C., Boland, E., Lux, L. J., Gaylord, S., Bann, C., Pierl, C. B., & Lohr, K. N.
Venue
Annals of Internal Medicine
Published
2016-03-01
Volume
164
Issue
5
Pages
331-341
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2291849082
Cited by
132
References
29
FWCI
13.39
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Funders
Agency for Healthcare Research and Quality (290-2012-00008i)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians. https://app.cochat.ai/papers/10.7326/m15-1813
The paper
Gartlehner, G., Gaynes, B. N., Amick, H. R., Asher, G. N., Morgan, L. C., Coker-Schwimmer, E., Forneris, C., Boland, E., Lux, L. J., Gaylord, S., Bann, C., Pierl, C. B., & Lohr, K. N. (2016). Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. https://doi.org/10.7326/m15-1813

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.